Autifony Therapeutics

📍 Stevenage, United Kingdom🗓 Founded 2011👥 39 employees💰 Last funded Jun 2019
Pharmaceutical Manufacturing🌐 autifony.com
Website LinkedIn
Autifony Therapeutics Limited (“Autifony”) is a clinical stage biotechnology company dedicated to developing new medicines to treat rare genetic CNS disorders by deploying its pioneering ion channel drug discovery platform.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2011
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in Autifony Therapeutics?
Autifony Therapeutics has 1 investors on record on gritt.io and 1 late-stage investors.
When did Autifony Therapeutics last raise funding?
The most recent investment in Autifony Therapeutics recorded on gritt.io was in June 2019.
When was Autifony Therapeutics founded?
Autifony Therapeutics was founded in 2011.
What industry is Autifony Therapeutics in?
Autifony Therapeutics operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Autifony Therapeutics based?
Autifony Therapeutics is headquartered in Stevenage, United Kingdom.